Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz, Thomas, Láng, István, Kahán, Zsuzsanna, Greil, R., Beslija, Semir, Stemmer, Salomon M., Kaufman, B., Petruzelka, L., Eniu, A., Anghel, Rodica, Koynov, K., Vrbanec, Damir, Pieńkowski, Tadeusz, Melichar, B., Spanik, S., Ahlers, S., Messinger, Diethelm, Inbar, Moshe J., Zielinski, Christoph: Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
BRITISH JOURNAL OF CANCER, 111 (11). pp. 2051-2057. ISSN 0007-0920 (2014)

[img]
Preview
Text
bjc2014504a.pdf - Published Version

Download (203kB) | Preview
Item Type: Article
Journal or Publication Title: BRITISH JOURNAL OF CANCER
Date: 2014
Volume: 111
Number: 11
Page Range: pp. 2051-2057
ISSN: 0007-0920
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
MTMT id: 2776321
DOI id: https://doi.org/10.1038/bjc.2014.504
Date Deposited: 2017. Sep. 18. 09:49
Last Modified: 2017. Sep. 18. 09:49
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11951

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year